STARS Webinar - Finding the Right Dose: Using Patient-Reported Data in Early Phase Clinical Trials-List of Terms

Pdf Summary

Here is a summary of the terms mentioned:<br /><br />1. Dose limiting toxicity: Serious side effects of a treatment that prevent an increase in dosage.<br /><br />2. Efficacy: The ability of a drug or surgery to produce the desired beneficial effect.<br /><br />3. Immunotherapy: Treatment that uses the patient's immune system to fight cancer by boosting or changing its function.<br /><br />4. Incidence: The rate of new cases or events over a specified period for the population at risk.<br /><br />5. Item library: A list of questions that can be selected for specific trials and patient groups.<br /><br />6. Maximum tolerated dose: The highest dose of a medicine or treatment that produces the desired effect without unacceptable side effects.<br /><br />7. Patient experience data: Information collected about patients' experiences with a disease or treatment, including the impact and patient preferences.<br /><br />8. Patient-reported outcomes (PRO): Measurements of a patient's health condition directly reported by the patient without interpretation by a clinician.<br /><br />9. Recommended phase 2 dose (RP2D): The dose identified in a phase 1 study for further investigation in future clinical trials.<br /><br />10. Registrational trial/pivotal trial: A clinical trial intended to provide evidence for FDA/EMA approval of a new treatment.<br /><br />11. Targeted therapy: Cancer treatment that uses drugs or substances to identify and attack specific cancer cells.<br /><br />These terms are important in the field of clinical trials, cancer treatment, and patient-centered care.

Meta Tag

Concept Dose-Limiting Toxicity

Concept Maximum Tolerated Dose

Concept Recommended phase 2 dose

Concept Patient-Reported Outcomes

Concept Efficacy

Keywords

Dose limiting toxicity

Efficacy

Immunotherapy

Incidence

Item library

Maximum tolerated dose

Patient experience data

Patient-reported outcomes (PRO)

Recommended phase 2 dose (RP2D)

Registrational trial/pivotal trial

Dose-Limiting Toxicity

Maximum Tolerated Dose

Recommended phase 2 dose

Patient-Reported Outcomes

Efficacy